EFFECT OF INFLUENZA VACCINES ON SUBPOPULATIONS OF BLOOD DENDRITIC CELLS

Cover Page


Cite item

Abstract

Aim. Study the effect of Vaxigrip split, Influvac subunit and Grippol plus immune-adjuvanted vaccines on the content of myeloid (mDC) and plasmacytoid (pDC) dendritic cells (DC) in blood of vaccinated healthy women. Materials and methods. Blood of 30 healthy women aged 18-50 years was studied at days 7 and 30 after the vaccination. pDC (CD14+CD16-/CD85k(ILT3)-PE/ CD123-PC5) and mDC (CD14+CD16-/CD85k(ILT3)-PE/CD33-PC5) immune phenotyping was carried out using mAbs (Beckman Coulter, France) and flow cytometer Cytomix FC-500 (Beckman Coulter, USA). Results. Use of unadjuvanted vaccines Vaxigrip and Influvac resulted in an increase of the numbers of mDC and pDC (p<0.05) in blood of the vaccinated only at day 7 of the observation. Grippol resulted in a more significant (2.2 - 3.6 times, p<0.05) increase of DC subpopulations (compared with unadjuvanted vaccines) at both day 7 and a month after the vaccination. Conclusion. Influenza vaccination activated innate effectors - the first component on the way of infection penetration - dendritic cells of both myeloid and lymphoid origin. Wherein, a more pronounced and prolonged effect of such activation is observed when immune-adjuvanted vaccine is used compared with subunit and split vaccines.

About the authors

E. A. Chromova

Mechnikov Research Institute of Vaccines and Sera

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

E. A. Akhmatova

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

S. A. Skhodova

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

I. A. Semochkin

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

V. G. Khomenkov

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

N. K. Akhmatova

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

M. P. Kostinov

Mechnikov Research Institute of Vaccines and Sera

Email: noemail@neicon.ru
Russian Federation

References

  1. Bergmann-Leitner E.S., Leitner W.W., Tsokos G.C. Complement 3d: from molecular adjuvant to target of immune escape mechanisms. Clin. Immunol. 2006, Nov; 121 (2): 177-185.
  2. Duraisingham S.S., Rouphael N., Cavanagh M.M. et al. Systems biology of vaccination in the elderly. Curr. Top. Microbiol. Immunol. 2013, 363: 117-142.
  3. Geginat J., Nizzoli G., Paroni M. et al. Immunity to pathogens taught by specialized human dendritic cell subsets. Front. Immunol. 2015, Oct 13; 6: 527.
  4. Iwasaki A., Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015, Apr; 16 (4): 343-353.
  5. Kang I., Hong M.S., Nolasco H. et al. Age-associated change in the frequency of memory CD4+ T cells impairs longterm CD4+ T cell responses to influenza vaccine. J. Immunol. 2004, 173:673-681.
  6. Martins K.A., Bavari S., Salazar A.M. Vaccine adjuvant uses of poly-IC and derivatives. Expert. Rev. Vaccines. 2015, Mar; 14 (3): 447-459.
  7. Moyer T.J., Zmolek A.C., Irvine D.J. Beyond antigens and adjuvants: formulating future vaccines. J. Clin. Invest. 2016, Mar 1; 126 (3): 799-808.
  8. Sasaki S., Sullivan M., Narvaez C.F. et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J. Clin. Invest. 2011, 121: 3109-3119.
  9. Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011, 109: 87-124.
  10. Schettinil J., Mukheijee P. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity. Clin. Dev. Immunol. 2008;2008:106321. doi: 10.1155/2008/106321. ll.Schijns V. Immunological concepts of vaccine adjuvant activity. Commentary. Curr. Op. Immunol. 2000, 12: 456-463.
  11. Trumpfheller C., Longhi M.P., Caskey M. et al. Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity. J. Intern. Med. 2012, Feb; 271 (2): 183-192.
  12. Wagar L.E., Gentleman B., Pircher H. et alflnfluenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response. PLoS ONE. 2011, 6: e23698.
  13. Wang C., Liu R, Zhuang Y. et al. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory. Vaccine. 2014, Sep 22; 32 (42): 5475-5483.
  14. Yoo S., Ha S.J. Generation of tolerogenic dendritic cells and their therapeutic applications. Immune Netw. 2016, Feb; 16 (1): 52-60.

Copyright (c) 2016 Chromova E.A., Akhmatova E.A., Skhodova S.A., Semochkin I.A., Khomenkov V.G., Akhmatova N.K., Kostinov M.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies